SEP 22, 2021 8:00 AM PDT

Cell therapy needs a data-driven and certified cleanroom-compatible CO₂ incubator

Speaker

Abstract
Date:  September 22, 2021
Time: 8:00am (PDT),  11:00am (EDT)
 
New technologies generating successful cell and gene therapy approaches have contributed to a global growth of institutions that cultivate stem cells, T cells and other primary cell types under stringent conditions. These cells are exquisitely reactive to their environment and challenging to manage. For any therapeutic designed for use in a human patient, careful safeguards are inherent to the development and production. Good manufacturing practices (GMP) must be followed. As part of GMP, working in a cleanroom setting helps to produce a therapy which is safe and effective, pure, and of high quality. Culturing cells in a cleanroom under GMP comes with new challenges, and require a CO incubator that can help meet these challenges by reducing risk to the therapy, including features to control particulates and contamination, compatibility with enhanced cleaning procedures, documentation to support validation processes and certification for ISO Class 5 and Grade A/B use in accordance with ISO 14644-1.
 
Learning Objectives
  • Review the global increase in cell and gene therapy applications
  • Describe the needs for cleanroom equipment
  • Explore attributes and certifications that make a CO incubator compatible for cleanroom work
  • Demonstrate that incubator performance can vary and how the parameters affect cultured cells
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
APR 26, 2022 7:00 AM PDT
C.E. CREDITS
APR 26, 2022 7:00 AM PDT
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
MAR 02, 2022 9:00 AM PST
C.E. CREDITS
MAR 02, 2022 9:00 AM PST
Date: March 02, 2022 Time: 9:00am (PST), 12:00pm (EST) Single cell RNA-seq is known to only capture a small fraction of the transcriptome of each cell. Often, this is due to inherent limitat...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
NOV 30, 2021 11:00 AM PST
C.E. CREDITS
NOV 30, 2021 11:00 AM PST
Date: November 30, 2021 Time: 11:00am (PDT), 2:00pm (EDT) In the recent years, measurable residual disease (MRD) assessment on multiple myeloma patients has gained increasing relevance. After...
Loading Comments...
Show Resources